Every year hundreds of thousands of cancer patients benefit from AmoyDx products and services. As diagnostic partner with AstraZeneca, Johnson & Johnson, Amgen, Eli Lilly, Merck, Eisai, Hengrui and BeiGene, AmoyDx provides diagnostic products and services for trials of drugs in clinical development and for clinical practice. AmoyDx^® ROS1 kit was the first approved companion diagnostic kit for Pfizer`s crizotinib by Japanese and South Korean authorities.

Our mission is to improve healthcare and patients` lives with superior & innovative products and services. Our vision is to be one of the global leading and most reliable suppliers of quality diagnostic products and services for personalized healthcare. We endeavor to accomplish this mission and vision by: 1. Adhering strictly to manufacturing standards to provide quality products. 2. Maintaining an unsurpassed level of customer experience and satisfaction. 3. Pursuing scientific innovation to provide customers with practical leading-edge technologies and value-added products. 4. Creating a world-class organization that contributes positively to the lives of our employees, our customers, the patients and the scientific community.

Amoy Diagnostics Co., Ltd. Memberships

Contact supplier